Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04877015 · ClinicalTrials.gov registry record · NA
Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease
A NA study, sponsored by Synergic Medical Technologies.
- Terminated
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT04877015 is a NA study that was terminated before completion, run by Synergic Medical Technologies. The registered enrollment target is 36 participants.
The verdict
NCT04877015, a NA study, was terminated before completion, sponsored by Synergic Medical Technologies.
- TERMINATED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within Parkinson's patients. vCR will be administered with a device called the VT Brain Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as levodopa and or deep brain stimulation. This study will include a dedicated sham that will aid in understanding true treatment effects from vCR.
Interventions
- DEVICE Active Vibrotactile Coordinated Reset (vCR)
- DEVICE Sham Vibrotactile Coordinated Reset (vCR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-12-07 |
| Est. Completion | 2022-10-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04877015
The ClinicalTrials.gov registry entry for NCT04877015 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Synergic Medical Technologies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Vibrotactile Coordinated Reset (vCR) is the first listed.
NCT04877015 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04877015 about?
NCT04877015 is a clinical study titled "Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease". The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within Parkinson's patients. vCR will be administered with a device called the VT Brain Glove. vCR is expected to provide patients with a non-invasive alternative to the most wid...
What is the current status of trial NCT04877015?
This trial is currently terminated. It is a NA study. The enrollment target is 36 participants. The study started on 2021-12-07. Estimated completion is 2022-10-14.
What interventions are being tested in trial NCT04877015?
The interventions under investigation include: Active Vibrotactile Coordinated Reset (vCR) (DEVICE), Sham Vibrotactile Coordinated Reset (vCR) (DEVICE).
Who is sponsoring clinical trial NCT04877015?
This trial is sponsored by Synergic Medical Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.